Growth in emerging markets may be slowing, but pharma sales there are still outpacing those everywhere else. And if recent numbers are any indication, AstraZeneca ($AZN) is topping its rivals for emerging markets expansion. AstraZeneca's sales in the developing world jumped by 14% over the last four quarters--four percentage points ahead of next-place companies Pfizer ($PFE) and Sanofi ($SNY)--and beat all comers quarter-by-quarter as well.
Emerging markets still beat elsewhere for Big Pharma growth, with AstraZeneca in the lead
Jun 23, 2015
Machinery Basics
Annual Outlook Report: Workforce
Hiring remains a major challenge in packaging, with 78% struggling to fill unskilled roles and 84% lacking experienced workers. As automation grows, companies must rethink hiring and training. Download the full report for key insights.
Download Now
Annual Outlook Report: Sustainability
The road ahead for CPGs in 2025 and beyond—<i>Packaging World</i> editors review key findings from a survey of 88 brand owners, CPG, and FMCG readers.
Download Now